Meeting of the Global Justice Information Sharing Initiative Federal Advisory Committee
This is an announcement of a meeting of the Global Justice Information Sharing Initiative (Global) Federal Advisory Committee (GAC) to discuss the Global Initiative, as described at http:// www.it.ojp.gov/global.
Notice of Relocation
Notice is hereby given that the Office of the Clerk of the Board of Immigration Appeals, Executive Office for Immigration Review, is moving to a new location.
Reports by Registrants of Theft or Significant Loss of Controlled Substances
DEA is amending its regulations regarding reports by registrants of theft or significant loss of controlled substances. There had been some confusion as to what constitutes a significant loss and when and how initial notice of a theft or loss should be provided to DEA. In this final rule, DEA clarifies the regulations and provides guidance to registrants regarding the theft, significant loss, and unexplained loss of controlled substances.
Adjudication of Claims of U.S. Nationals Against the Government of Cuba
This notice announces the commencement by the Foreign Claims Settlement Commission of a program for adjudication of certain property claims of United States nationals against the Government of Cuba.
Meeting of the Coordinating Council on Juvenile Justice and Delinquency Prevention
The Coordinating Council on Juvenile Justice and Delinquency Prevention (Council) is announcing the September 9, 2005, meeting of the Council.
Controlled Substances: Proposed Revised Aggregate Production Quotas for 2005
This notice proposes revised 2005 aggregate production quotas for controlled substances in Schedules I and II of the Controlled Substances Act (CSA).
Schedules of Controlled Substances: Placement of Embutramide Into Schedule III
This proposed rule is issued by the Deputy Administrator of the Drug Enforcement Administration (DEA) to place the substance embutramide, including its salts, into Schedule III of the Controlled Substances Act (CSA). This proposed action is based on a recommendation from the Acting Assistant Secretary for Health of the Department of Health and Human Services (DHHS) and on an evaluation of the relevant data by DEA. If finalized, this action will impose the regulatory controls and criminal sanctions applicable to Schedule III on those who handle embutramide and products containing embutramide.
Schedules of Controlled Substances: Placement of Pregabalin Into Schedule V
This final rule is issued by the Deputy Administrator of the Drug Enforcement Administration (DEA) to place the substance pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid], including its salts, and all products containing pregabalin into Schedule V of the Controlled Substances Act (CSA). As a result of this rule, the regulatory controls and criminal sanctions of Schedule V will be applicable to the manufacture, distribution, dispensing, importation and exportation of pregabalin and products containing pregabalin.
Privacy Act of 1974: Implementation
The Department of Justice (DOJ), Federal Bureau of Investigation (FBI), proposes to exempt a new system of records entitled the Terrorist Screening Records System (TSRS) (JUSTICE/FBI 019) from subsections (c)(3) and (4); (d)(1), (2), (3), and (4); (e)(1), (2), (3), (5), and (8); and (g) of the Privacy Act pursuant to 5 U.S.C. 552a(j) and (k). As explained in the proposed rule, the exemption is necessary to avoid interference with the law enforcement, intelligence, and counterterrorism functions and responsibilities of the FBI and its Terrorist Screening Center (TSC). Public comment is invited.
Privacy Act of 1974; System of Records
The Federal Bureau of Investigation (FBI) proposes to add a system of records to its inventory of record systems subject to the Privacy Act of 1974 (5 U.S.C. 552a), as amended. The FBI is establishing a new system of records to cover records maintained by the Terrorist Screening Center (TSC). These records were previously covered by the FBI Central Records System (Justice/FBI-002), last published in full text on February 20, 1998 (63 FR 8671) and amended in part on March 29, 2001 (66 FR 17200). Public comments are invited.